Spring 2019
"Genetic Determinants of Late Effects in Childhood Cancer"
Monica Gramatges, MD, PhD
Texas Children's Hospital
"Social Determinants of Late Effects in Childhood Cancer Survivors"
Michael Scheurer, PhD, MPH
Texas Children's Hospital
"Passport for Care: Clinical and Research Applications."
Panel Discussion
Fall 2018
Pulmonary Toxicity
Lauren Faricy, MD
University of Vermont Medical Center
Second Cancers Risk Assessment and Screening
Spring 2018
"Treatment Associated Breast Cancer"
Lisa Diller, MD
Dana Farber Cancer Institute
"Treatment Associated Thyroid Cancer" Ari Wassner, MD
Boston Children's Hospital
"Hereditary Cancer Predisposition in Survivorship Care:
Junne Kamihara, MD, PhD
Dana Farber Cancer Institute/Boston Children's Hospital
Spring 2017
Cancer Genetics
"Inherited Cancer Syndromes and Implications for Survivorship Care"
Tom Renaud, MD
Rhode Island Hospital/Hasbro Children's Hospital
"Genetic Predisposition Syndromes in Pediatric Survivorship Clinic"
Lauren Massingham, MD
Rhode Island Hospital/Hasbro Children's Hospital
"A Genetic Counselors Perspective on Genetics and Pediatric Oncology"
Jennifer Schwab MS CGC
Rhode Island Hospital/Hasbro Children's Hospital
Fall 2016
Psychologic Disorders
“Update on psychologic disorders in childhood cancer survivors: integrating psychologic care in survivorship programs”
Christopher Recklitis, PhD
Dana Farber Cancer Institute
Spring 2016
Healthy Lifestyles
"Male sexuality and intimacy across the life span in patients after cancer therapy"
Stanton Honig, MD
Yale School of Medicine
"Interventions targeting obesity and physical activity in cancer survivors" Melinda Irwin, PhD, MPH
Yale School of Public Health
"Practical Aspects of Nutritional Recommendations for Young Adult Cancer Survivors"
Maura Harrigan, MS, RDN, CSO
Yale School of Public Health
"The Benefits of Iintegrative Medicine"
Ather Ali, ND, MPH, MHS
Yale School of Medicine
Fall 2015
Neurotoxicity in Childhood Cancer Survivors
"Brief Overview of Neurotoxicity"
Nichole Ullrich, MD, PhD gave talk on behalf of Peter Manley, MD
DanaFarber Cancer Institute
"Peripheral Neuropathies"
Kristin Brown, Physical Therapy
Rhode Island Hospital/Hasbro Children's Hospital
"Treatment Associated Vasculopathies"
Nicole Ullrich, MD, PhD
Boston Children's Hospital/Dana Farber Cancer Institute
Fall 2014
Transition to Adult Care
“Got Transition: Overview of Transition from Pediatric to Adult care"
Niraj Sharma MD
Boston Children's Hospital
“Transition the Pediatric Oncologists Perspective”
Lisa Kenney MD
Boston Children's Hospital/Dana Farber Cancer Institute
“Implementing Transition Practices into Childhood Cancer Survivor Care”
Group Discussion
Fall 2013
Renal Toxicity
Adam Weinstein, MD
Dartmouth-Hitchcock Medical Center
Avarum Traum, MD
Boston Children's Hospital
Spring 2013
Male Fertility
"Hypoandrogenism after Cancer Treatment"
Laurie Cohen, MD
Boston Children's Hospital
"Infertility after Cancer Treatment"
Richard Yu, MD, PhD
Boston Children's Hospital
"Approaches to Fertility Preservation"
Leena Nahata, MD
Boston Children's Hospital
" Sexual Health "
Sharon Bober, PhD
Dana Farber Cancer Institue
Fall 2012
Bone Toxicity
"Overview of Bone Growth and Assessment of BMD"
Nina Ma, MD
Boston Children's Hospital
"Overview of Skeletal Toxicity in Childhood Cancer Survivors"
Lynda Vrooman, MD
Dana Farber Cancer Institute
"Endocrine Assessment and Interventions for Skeletal Toxicity"
Karen Loechner, MD
Dartmouth-Hitchcock
"Orthopedic complications and interventions"
Kevin Raskin, MD
Massachusetts General Hospital
Fall 2011
Female Fertility
“Risk factors for and prediction of ovarian failure in childhood cancer survivors”
Erin E. Barlow, MD
UMass Memorial Medical Center
“Fertility preservation for female childhood cancer survivors”
Sara Barton, MD
Brigham and Women's Hospital
“Costs and resources for fertility preservation”
Elyse Levin-Russman, LCSW
MassGeneral Hospital for Children
Spring 2011
Second Cancers
"Chemotherapy Associated Second Cancers"
Howard Weinstein, MD
MassGeneral Hospital
"Radiation Associated Second Cancers"
Karen Marcus, MD
Dana Farber Cancer Institute
"Hereditary Cancer Predisposition"
David Sweetser, MD
MassGeneral Hospital
"Genetic Counseling/Testing for Cancer Predisposition"
Kathy Schneider, CGC
Dana Farber Cancer Institute
Neurocognitive Late Effects
"Neurocognitive Late Effects for Childhood Cancer Survivors"
Christine Trask, PhD
Rhode Island Hospital/Hasbro Children's Hospital
"Psychopharmacologic therapy for Neurocognative Late Effects"
Annah Abrams, MD
MassGeneral Hospital for Children
Fall 2010
Cardiotoxicity
Renee Margossian, MD
Boston Children's Hospital
Virginia Beggs, NP
Dartmouth-Hitchcock Medical Center
Spring 2010
Endocrine Toxicity
Laurie Cohen, MD
Boston Children's Hospital
Kenney LB, Ames B, Michaud AL, Williams DN, Manley PE, Ulrich NJ.
The management of childhood cancer survivors at risk for stroke: A Delphi survey of regional experts, Pediatr Blood Cancer. 2018.
Frederick N., Revette A, Campbell K, Moss K, Speckhart A, Kenney L, Mack J. Barriers and Facilitators to Sexual and Reproductive Health Communication between Pediatric Oncology Clinicians and Adolescent and Young Adult Patients: The Clinician Perspective. Pediatr Blood Cancer. 2018.
Welch JJG, Kenney LB, Hirway P, Usmani GN, Kadan-Lottick N, Grewal SS, Huang M, Bradeen H, Alder J, Diller L, Schwartz CL
Understanding predictors of continued long-term pediatric cancer care across the region: a report from the Consortium for New England Childhood Cancer Survivors. Pediatr Blood Cancer. 2017.
Kenney LB, Bradeen H, Kadan-Lottick NS, Diller L, Homans A, Schwartz CL.
The current status of follow-up services for childhood cancer survivors, are we meeting goals and expectations: A report from the consortium for New England childhood cancer survivors. Pediatr Blood Cancer. 2011.
Disclaimer: This website is not a substitute for a doctor's medical advice or specific care services available through your medical provider. A listing on this website does not imply an affiliation with or endorsement by CONNECCS or its member institutions.